Andrew Maleki currently serves as Chief Financial Officer at Surrozen since October 2025. Prior to this role, Andrew held positions related to corporate development and operations at Lassen Therapeutics from May 2021 to October 2025, and at Jazz Pharmaceuticals from October 2018 to April 2021. Andrew's early experience includes roles as an intern at Lightstone Ventures and a consultant at Omega Therapeutics. From June 2014 to May 2016, Andrew was a Senior Manager in Corporate Development and Strategy at PureTech Health, and from September 2012 to June 2014, Andrew worked as a Senior Analyst at ClearView Healthcare Partners. Andrew received a Master of Business Administration (MBA) from Harvard Business School (2016-2018) and a Bachelor of Arts (B.A.) in Economics and Biology from Yale University (2008-2012).
This person is not in any teams
This person is not in any offices